165 related articles for article (PubMed ID: 29039106)
1. Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.
Skoczen SL; Stern ST
Methods Mol Biol; 2018; 1682():223-239. PubMed ID: 29039106
[TBL] [Abstract][Full Text] [Related]
2. Stable isotope method to measure drug release from nanomedicines.
Skoczen S; McNeil SE; Stern ST
J Control Release; 2015 Dec; 220(Pt A):169-174. PubMed ID: 26596375
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing Pharmacokinetics of Marketed Nanomedicine Formulations Using a Stable Isotope Tracer Assay.
Skoczen SL; Snapp KS; Crist RM; Kozak D; Jiang X; Liu H; Stern ST
ACS Pharmacol Transl Sci; 2020 Jun; 3(3):547-558. PubMed ID: 32566919
[TBL] [Abstract][Full Text] [Related]
4. Ultrafiltration vs equilibrium dialysis for determination of free fraction.
Bowers WF; Fulton S; Thompson J
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():49-60. PubMed ID: 6705427
[TBL] [Abstract][Full Text] [Related]
5. When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics?
Stern ST; Martinez MN; Stevens DM
Drug Metab Dispos; 2016 Dec; 44(12):1934-1939. PubMed ID: 27670412
[TBL] [Abstract][Full Text] [Related]
6. Ultrafiltration and subsequent high performance liquid chromatography for in vivo determinations of the protein binding of etoposide.
Liliemark E; Herngren L; Pettersson B; Peterson C; Liliemark J
Cancer Lett; 1996 Aug; 106(1):91-6. PubMed ID: 8827051
[TBL] [Abstract][Full Text] [Related]
7. Determination of unbound docetaxel and paclitaxel in plasma by ultrafiltration and liquid chromatography-tandem mass spectrometry.
Mortier KA; Lambert WE
J Chromatogr A; 2006 Mar; 1108(2):195-201. PubMed ID: 16472531
[TBL] [Abstract][Full Text] [Related]
8. Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry.
Cheng Y; Ho E; Subramanyam B; Tseng JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):67-73. PubMed ID: 15282095
[TBL] [Abstract][Full Text] [Related]
9. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
Mayer LD; St-Onge G
Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
[TBL] [Abstract][Full Text] [Related]
10. Measurement of total and free docetaxel concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
Rigo-Bonnin R; Cobo-Sacristán S; Gonzalo-Diego N; Colom H; Muñoz-Sánchez C; Urruticoechea A; Falo C; Alía P
J Pharm Biomed Anal; 2016 Jan; 117():140-9. PubMed ID: 26350560
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Temperature-Dependent Drug Release of Solubilizing Nanoformulations Using the SITUA.
Stern ST; Skoczen SL; Park YH
Methods Mol Biol; 2024; 2789():301-311. PubMed ID: 38507012
[TBL] [Abstract][Full Text] [Related]
12. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
Liu Z; Li F; Huang Y
Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
[TBL] [Abstract][Full Text] [Related]
13. Determination of drug binding to plasma proteins using competitive equilibrium binding to dextran-coated charcoal.
Berezhkovskiy LM
J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):595-608. PubMed ID: 16841186
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay.
Hwang D; Vinod N; Skoczen SL; Ramsey JD; Snapp KS; Montgomery SA; Wang M; Lim C; Frank JE; Sokolsky-Papkov M; Li Z; Yuan H; Stern ST; Kabanov AV
Biomaterials; 2021 Nov; 278():121140. PubMed ID: 34634661
[TBL] [Abstract][Full Text] [Related]
15. Bioanalysis of therapeutic peptides: differentiating between total and anti-drug antibody bound drug using liquid chromatography-tandem mass spectrometry quantitation.
Heinig K; Wirz T; Schick E; Guenzi A
J Chromatogr A; 2013 Nov; 1316():69-77. PubMed ID: 24119751
[TBL] [Abstract][Full Text] [Related]
16. [Anaerobic serum ultrafiltration--a new method for determination of protein-binding rates of drugs under physiological conditions (author's transl)].
Paschen K; Bautz W; Bohner J
Arzneimittelforschung; 1976; 26(12):2137-41. PubMed ID: 1037262
[TBL] [Abstract][Full Text] [Related]
17. The influence of volume ratio of ultrafiltrate of sample on the analysis of non-protein binding drugs in human plasma.
Dong WC; Zhang JF; Hou ZL; Jiang XH; Zhang FC; Zhang HF; Jiang Y
Analyst; 2013 Nov; 138(24):7369-75. PubMed ID: 24165752
[TBL] [Abstract][Full Text] [Related]
18. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
Weiss HM; Gatlik E
J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
[TBL] [Abstract][Full Text] [Related]
19. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
Eriksson MA; Gabrielsson J; Nilsson LB
J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
[TBL] [Abstract][Full Text] [Related]
20. Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
Wang C; Wang Q; Yuan Z; Liu W; Gu J; Zhang L
Drug Dev Ind Pharm; 2010 Mar; 36(3):307-14. PubMed ID: 19670965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]